These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10568160)

  • 41. Long-term postmenopausal hormone therapy and endometrial cancer risk: a study by Doherty et al.
    Odem RR; Moniz MH; Allsworth JE; Bleckman CR; Omicioli VA; Lawrence LT; Thaker PH
    Am J Obstet Gynecol; 2007 Aug; 197(2):213-4; discussion e1-5. PubMed ID: 17689656
    [No Abstract]   [Full Text] [Related]  

  • 42. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
    Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
    J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [High factor VIII as a risk factor for venous thrombosis].
    Elishkewitch K; Berliner S; Eldor A; Shapira I
    Harefuah; 2001 Dec; 140(12):1122-4, 1232. PubMed ID: 11789291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Venous thrombosis: prevalence of prothrombotic defects in north Indian population.
    Bhattacharyya M; Kannan M; Chaudhry VP; Saxena R
    Indian J Pathol Microbiol; 2003 Oct; 46(4):621-4. PubMed ID: 15025358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exogenous hormones, the risk of venous thromboembolism, and activated protein C resistance.
    Mueck AO
    Menopause; 2010; 17(6):1099-103. PubMed ID: 20975607
    [No Abstract]   [Full Text] [Related]  

  • 47. Elevated factor VIII: an unfamiliar risk factor for cerebral venous thrombosis.
    Albert NE; Hamarich AY; Joshi A
    J Am Osteopath Assoc; 2012 Mar; 112(3):140-1. PubMed ID: 22411968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renewed interest in haemostasis changes induced by oral contraceptives (OCs).
    Kluft C
    Thromb Haemost; 2000 Jul; 84(1):1-3. PubMed ID: 10928460
    [No Abstract]   [Full Text] [Related]  

  • 49. Oral contraceptive pills and hormonal replacement therapy and thromboembolic disease.
    Mammen EF
    Hematol Oncol Clin North Am; 2000 Oct; 14(5):1045-59, vii-viii. PubMed ID: 11005033
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
    Haematologica; 2004 Nov; 89(11):1286. PubMed ID: 15531449
    [No Abstract]   [Full Text] [Related]  

  • 51. High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.
    Oger E; Lacut K; Van Dreden P; Bressollette L; Abgrall JF; Blouch MT; Scarabin PY; Mottier D
    Haematologica; 2003 Apr; 88(4):465-9. PubMed ID: 12681975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bilateral Renal Vein Thrombosis due to Elevated Factor VIII Levels.
    Patole S; Ramya I
    J Assoc Physicians India; 2015 Aug; 63(8):87-8. PubMed ID: 27604446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beta-receptor blockade decreases elevated plasma levels of factor VIII:C in patients with deep vein thrombosis.
    Hoppener MR; Kraaijenhagen RA; Hutten BA; Büller HR; Peters RJ; Levi M
    J Thromb Haemost; 2004 Aug; 2(8):1316-20. PubMed ID: 15304037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated plasma factor VIII levels in patients with venous thrombosis--constitutional risk factor or secondary epiphenomenon?
    Ryan K; O'Donnell JS
    Thromb Res; 2012 Feb; 129(2):105-6. PubMed ID: 22032801
    [No Abstract]   [Full Text] [Related]  

  • 55. [Internal jugular vein thrombosis in two patients treated with oral contraceptives].
    Mañas-García MD; Marchán-Carranza E; Ceres-Alabau F; Rodríguez-Alvarez S
    Med Clin (Barc); 2006 Jul; 127(5):196. PubMed ID: 16834957
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor VIII levels and blood group antigens.
    McCallum CJ; Peake IR; Newcombe RG; Bloom AL
    Thromb Haemost; 1983 Oct; 50(3):757. PubMed ID: 6417823
    [No Abstract]   [Full Text] [Related]  

  • 57. Deep vein thrombosis.
    Rossi G; Rossi V
    Lancet; 2005 Jul 9-15; 366(9480):118-9; author reply 119-20. PubMed ID: 16005324
    [No Abstract]   [Full Text] [Related]  

  • 58. The relationship between coagulation factor VIII and ABO blood group status.
    McLellan DS; Knight SR; Aronstam A
    Med Lab Sci; 1988 Apr; 45(2):131-4. PubMed ID: 3145379
    [No Abstract]   [Full Text] [Related]  

  • 59. Variations of factor VIII:C plasma levels with respect to the blood group ABO.
    Jeanne M; Piquet Y; Ivanovic Z; Vezon G; Salmi LR
    Transfus Med; 2004 Apr; 14(2):187-8. PubMed ID: 15113385
    [No Abstract]   [Full Text] [Related]  

  • 60. Major blood group antigens--a determinant of factor VIII levels in blood?
    Mohanty D; Ghosh K; Marwaha N; Kaur S; Chauhan AP; Das KC
    Thromb Haemost; 1984 Jul; 51(3):414. PubMed ID: 6437009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.